or
forgot password
  • cancer clinical trials in alabama

  • Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    Clearview Cancer Institute
    University of South Alabama Mitchell Cancer Institute
    Providence Hospital
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Clearview Cancer Institute
    Mobile Infirmary Medical Center
    Providence Hospital
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Providence Hospital
    Mobile, Alabama 36608
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Children's Hospital of Alabama at University of Alabama at Birmingham

    Trial Locations
    Children's Hospital of Alabama at University of Alabama at Birmingham
    University of South Alabama Mitchell Cancer Institute
    Kidney Cancer
    Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    Florence, Alabama
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    University of South Alabama
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Leukemia, Myelodysplastic Syndromes
    A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma
    University of Alabama at Birmingham Medical Center
    Birmingham, Alabama 35233
    Cancer
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    UAB Comprehensive Cancer Center

    Trial Locations
    UAB Comprehensive Cancer Center
    University of South Alabama Mitchell Cancer Institute
    Leukemia
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    University of South Alabama
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Breast Cancer
    First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
    Research Site
    Alabaster, Alabama
    Colorectal Cancer
    Preoperative Treatment of Patients With High Risk Thymoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Thymoma
    Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer
    GSK Investigational Site
    Birmingham, Alabama 35209
    Lung Cancer, Non-Small Cell
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of South Alabama
    Mobile, Alabama 36693
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Breast Cancer, Metastatic Cancer
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    University of Alabama
    Birmingham, Alabama
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Mycoses, Candidiasis, Invasive, Candidemia
    Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
    University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic
    Birmingham, Alabama 35294-0006
    Cutaneous T-Cell Lymphoma
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    University of Alabama at Birmingham
    Providence Hospital
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
    University fo Alabama at Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
    GSK Investigational Site
    Birmingham, Alabama 35209
    Neoplasms, Prostate, Prostate Cancer
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Shelby Dermatology

    Trial Locations
    Shelby Dermatology
    Pediatric Care Center of NE Alabama
    Total Skin and Beauty Dermatology Center
    Pediatric & Adult Asthma and Allergy, P.C.
    Metro Pediatrics, P.C
    Southview Dermatology
    Ruth A Yates
    Atopic Dermatitis